InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
64,049.82
(
-0.30%
)
Post# of 252302
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

acgood

Send PM Follow Ignore
Followers 18
Posts 1093
Boards Moderated 0
Alias Born 05/12/2007

acgood

Re: Summer2762 post# 141306

Friday, 05/04/2012 12:07:34 PM

Friday, May 04, 2012 12:07:34 PM

Post# of 252302

I prefer if it were ALK. However, based on the suspense they created, it seems like it is not. If it's not ALK or, better put, if the signal for the ALK subset is not there, I would be worried.



I'd much rather have a signal in ANOTHER subpopulation of NSCLC than just ALK. The interim analysis being discussed is on the order of 100 pts, so there will not be very many ALK patients. ALK (for that reason) was not one of the 4 prespecified analysis groups, and the signal is in one of those 4 (well three, since "all comers" was ruled out)

Opinions and comments may have been previously posted @BioDueDiligence, at www.biotechduediligence.com, or disseminated to Chimera Research Group subscribers.

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up